EBIT: Income before interest and taxes.
BioNxt Solutions Inc. (BNXTF) had EBIT of $-2.05M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.09M |
|
-- |
|
-- |
|
$2.05M |
|
$-2.05M |
|
$-1.04M |
|
$-3.09M |
|
$-3.14M |
|
$-3.09M |
|
$-3.09M |
|
$-3.09M |
|
$-3.14M |
|
|
EBIT |
$-2.05M |
$-2.05M |
|
125.25M |
|
125.25M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.05M |
|
$0.15M |
|
$0.19M |
|
$0.24M |
|
$4.80M |
|
$0.77M |
|
$0.77M |
|
$5.58M |
|
$-5.33M |
|
$-5.33M |
|
$-5.33M |
|
129.54M |
|
| Cash Flow Statement Financials | |
$-0.43M |
|
$0.05M |
|
$0.35M |
|
$0.04M |
|
$0.01M |
|
$-0.03M |
|
$1.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-0.17 |
|
-0.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
58.03% |
|
58.03% |
|
-1272.07% |
|
67.89% |
|
$-0.04 |
|
$-0.00 |
|
$-0.00 |
|